碳锌和碱性电池的金属回收的研究

研究了废碳锌电池和碱性电池中金属锌和金属锰的回收.经过破碎、分选、制作球团等处理,在500'℃条件下可有效回收金属锌,在1500℃条件下可有效回收金属锰.     

γ-氨基丁酰胺的合成研究

γ-氨基丁酰胺在食品,医药等领域有着重要作用,但是现有合成路线繁琐、反应条件苛刻、最终产率较低.本文设计以γ-氨基丁酸为原料,经过酰化、氨解作用合成γ-氨基丁酰胺.同时考察了不同的反应条件对产品收率的影响.工艺成熟,适宜工业化生产.     

三组分反应合成多官能团化α-氰基噻吩的简便方法

本文报道了一种利用多组分反应合成α-氰基噻吩的新方法. 在碱存在条件下, β-二羰基化合物、二硫化碳和溴乙腈经过连续的多步反应, “一锅”合成多官能团化的α-氰基噻吩. 该方法简洁, 条件温和, 产率高.     

氯化铜催化偶联合成4-烷基联苯

4-烷基联苯是重要的液晶中间体. 以氯化铜为C—C键偶联反应催化剂, 经过对溴联苯的Grignard试剂直接与溴代烷烃发生偶联反应, 成功合成了一系列4-烷基联苯类化合物, 部分化合物产率高达91%左右, 并对其反应条件进行了初步研究; 所合成化合物结构都经过元素分析、红外光谱、核磁共振氢谱和质谱鉴定. 与现有方法相比, 此合成方法收率高、环境友好、成本相对较低.     

废茶油的精制及其合成生物柴油的研究

本文以废茶油为原料,经过脱胶脱酸等预处理后与甲醇进行酯交换反应制取生物柴油.探讨了反应时间、反应温度、醇-油摩尔比和催化剂用量等因素对废茶油-甲醇酯交换反应的影响,并且采用正交实验优化合成条件,确定了反应的最佳操作条件以及影响反应的关键因素.研究结果表明,酯交换反应进行的最佳反应条件为:醇油摩尔比为25:1、催化剂用量为油重的1.0%、反应时间为30min、反应温度为60℃,茶油酸甲酯产率77.34%.     

磺化笼型介孔碳催化的1,1-二乙酸酯的选择性合成

以磺化的笼型介孔碳为催化剂温和、高效、高选择性地合成了缩羰基二乙酸酯. 在室温和无溶剂条件下,用磺化的笼型介孔碳作催化剂使醛类化合物与乙酸酐之间在5~12 min内反应生成1,1-二乙酸酯,产率高达89%~98%. 在相同条件下酮类化合物不会发生此反应. 反应后催化剂经过简单的处理即可回收利用,回收利用7次活性无明显降低.     

O_2参与下FeCl_2催化的分子内氧化反应构建异噁唑杂环

发展了一种廉价金属盐FeCl_2催化氧气氧化下,高效、环保且简洁合成多取异噁唑衍生物的新方法.通过对金属盐来源和碱等反应条件的优化,确立了最佳的反应条件.在此反应条件下合成了19个新型多取代3,5-二芳基异噁唑衍生物,并成功培养了一个单晶,产率在80%～90%之间.经过~1H NMR、~(13)C NMR、元素分析及X单晶衍射确证了所得目标化合物的结构.     

7-(2-溴-5-氯苄氧基)-3,4-二氢萘-1(2H)-酮的合成

选用2-溴-5-氯苯甲酸为起始原料,经过还原、氯化及醚化制备抗丙肝新药维拉帕维的关键中间体7-(2-溴-5-氯苄氧基)-3,4-二氢萘-1(2H)-酮.并考察了还原反应中溶剂,和醚化反应中缚酸剂等反应条件对收率的影响.确定较佳的反应条件:还原反应选用THF作为溶剂;醚化反应选用碳酸钾作为缚酸剂,DMF作为溶剂.三步总收率66.5%,产物经过1H NMR和MS确认.     

三价铑催化苯甲酰胺与醌的C–H活化偶联(英文)

三价铑在氧化条件下催化N-烷基苯甲酰胺与醌反应生成芳基醌.在氧化还原中性条件下,经过偶联和内酯化反应可以得到2-羟基-6H-苯并[c]吡喃-6-酮.     

碱性离子液体催化“一锅法”合成1,4-二氢吡喃并[2,3-c]吡唑

在碱性离子液体氢氧化1-丁基-3-甲基咪唑([bmim]OH)催化作用下,由芳香醛、丙二腈、苯甲酰乙酸乙酯和肼或苯肼"一锅法"合成了一系列1,4-二氢吡喃并[2,3-c]吡唑化合物.实验中考察了催化剂、反应温度、催化剂用量、溶剂对反应的影响,确定了最优反应条件,给出了可能的反应机理.此外催化剂可以方便地收回,且循环使用四次其催化活性并没有显著降低.目标产物经过了1H NMR,IR,MS和元素分析确证.合成方法条件温和、反应时间短、产率高且对环境友好.     

无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应

开发了无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应.应用该反应在甲醇中回流,以39%~83%的收率合成了一系列4-(N-(2,2-二氟乙基)(N-杂环芳基甲基)氨基)-5,5-二取代呋喃-2(5H)-酮,其结构经1H NMR,13C NMR和HR-ESI-MS表征,并进一步通过3-氯-4-(N-2,2-二氟乙基)(N-嘧啶-5-基甲基胺基)-5,5-螺(4-甲氧基环己基)呋喃-2(5H)-酮(8)的晶体衍射间接证实.测试了所合成化合物的生物活性,结果表明,在600μg·mL^-1浓度时4-(N-2,2-二氟乙基)(N-6-氯吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3a)和4-(N-2,2-二.氟乙基)(N-6-氟吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3c)对桃蚜的死亡率均为100%.     

Complete 1H, 13C and 15N NMR assignment of tirapazamine and related 1,2,4-benzotriazine N-oxides

1H, 13C and 15N NMR measurements (1D and 2D including 1H--15N gs-HMBC) have been carried out on 3-amino-1, 2,4-benzotriazine and a series of N-oxides and complete assignments established. N-Oxidation at any position resulted in large upfield shifts of the corresponding N-1 and N-2 resonances and downfield shifts for N-4 with the exception of the 3-amino-1,2,4-benzotriazine 1-oxide in which a small upfield shift of N-4 was observed. Density functional GIAO calculations of the 15N and 13C chemical shifts [B3LYP/6-31G(d)//B3LYP/6-311+G(2d,p)] gave good agreement with experimental values confirming the assignments. The combination of 13C and 15N NMR provides an unambiguous method for assigning the 1H and 13C resonances of N-oxides of 1,2,4-benzotriazines.     

Michael versus retro-Michael reaction in the regioselective synthesis of N-1 and N-3 uracil adducts

By controlling the temperature or reaction time in the base-catalysed Michael-type addition of 5-substituted uracil derivatives we were able to synthesise N-1 or N-3 uracil adducts using methyl acrylate and acrylonitrile as acceptors. The mechanism of this chemical inequivalence was established using ¹H NMR spectroscopic studies. The investigations revealed that formation of the N-1 adduct was achievable under kinetically controlled conditions irrespective to the type of the base used (TEA, DBU). In turn, synthesis of the N-3 adducts proceeded from the initially formed N-1,N-3 diadduct via a retro-Michael reaction which dominates at elevated temperature or prolonged reaction time.     

1H, 13C and 15N NMR observations on the protonation of 1- and 3-deazapurine

Using ¹H, ¹³C and ¹⁵N NMR it has been concluded that 3-deazarpurine protonates exclusively at N-1 with a pK of about 5.6. The base exhibits rapid tautomerism with proportions of 70:30, with the N–7-H tautomer in the majority. The salt exists predominantly as the N-7-H tautomer. 1-Deazapurine protonates essentially in a 1:1 ratio at N-3 and at the imidazole ring, with a pK of about 3.1. This base also exhibits rapid tautomerism with proportions of 30:70, this time with the N-9-H in the majority. The salt also exists in a tautomcric mixture with approximately equal proportions. One form has N-3 and N-9 bearing hydrogens and the other has N-7 and N-9 bearing hydrogens.     

Regioselective protection of hydantoins – essential for hydantoin based anti-epileptic drugs

The synthesis and NMR elucidation of six novel mono- and bis-Boc protected hydantoins are reported. The hydantoins 5-methylhydantoin, 5,5-dimethylhydantoin and a pentacycloundecane hydantoin exhibit an increase in substitution and steric hindrance at C-5. Kinetic and reagent controlled monoprotection of the smaller hydantoins achieve regioselective protection at N-1 while the bulky cage hydantoin is protected at N-3′. Hydantoin based anti-epileptic drugs such as 5,5-diphenylhydantoin require regioselective substitution at N-3′ for enhanced pharmaceutical activity. The study enhances our understanding of the activity of the nitrogen atoms on hydantoin rings.     

Complete 1H and 13C NMR spectral assignment of benzo[d]isothiazole derivatives and of an isoindole isoster

The complete (1)H and (13)C NMR assignments of the novel compound methyl 2-amino-3-(benzo[d]isothiazol-3-yl)propanoate (1), of 3-amino-5-methylbenzo[d]isothiazole (2) and N-(t-butyloxycarbonyl)-2-aminobenzo[d]isothiazol-3(2H)-one (3) and of the desulfurated isostere of 3, N-(t-butyloxycarbonyl)-2-aminoisoindolin-1-one (4), using 1D and 2D NMR techniques, including COSY, INADEQUATE, HSQC, and HMBC experiments are reported.     

Selective monodeoxygenation of quinoxaline-amino acid and ester dioxides

Trimethyl phosphite selectively removes the N-1-oxygen in N-(3-methyl-2-quinoxaloyl) L-α-amino ester-1,4-dioxides, whereas it removes the N-4-oxygen in the corresponding series of dioxides lacking the C₃-Me. This selectivity reversal reflects the relative strength of the intrahydrogen-bridging to the N-1-oxygen. The monoxides having the favourable N-oxygen are not reduced to the quinoxalines, implying that the reagent requires doubling of the N-oxide function for deoxygenation. However, alkaline sodium dithionite removes the N-1-oxygen in both series of the amino acid-dioxides, as well as in the parent quinoxaline-2-carboxylic acid-dioxides, a result that contradicts the report stating removal of the N-4-oxygen. The N-oxygenated quinoxalinium ion ($\text{m}\text{e}$ 145 or 159) prevails in the MS of the 4-oxides, but it is not observed (<1%) for the isomeric 1-oxides. ¹H NMR, ¹³C NMR and UV spectral data also offer diagnostic criteria for differentiation between the isomeric 1- and 4-oxides. Aryl-heteryl “interaction” (as revealed by ¹H NMR, though not by ¹³C NMR in the aromatic amino ester dioxides) is not manifested in the corresponding monoxides.     

N-5-(1H-1,2,4-三唑基）-N'-芳甲酰基脲的合成与生物活性

以5-氨基-1H-1，2，4-三唑-3-羧酸与酰基异氰酸酯反应，合成了15个新的N- 5-（1H-1，2，4-三唑基）-N'-芳甲酰基脲，用核磁共振氢谱、红外光谱和元素分 析确证了其结构，并进行了室内生物活性测试。生测试验证明部分酰基脲类化合物 具有良好的植物生长调节活性，其中N-5（3-羧基-1，2，4-三唑基）-N'-o-氯苯甲 酰基脲、N-5-（3-羧基-1，2，4-三唑基）-N'-o-溴苯甲酰基脲和N-5-(3-羧基-1， 2，4-三唑基）-N'-p(或m)-甲基苯甲酰基脲具有优良的生长素活性。     

一步法合成N-1,3-二羟基丙烷-2-基烷基乙酰胺

以5-氨基烷基-2,2-二甲基-1,3-二噁烷为起始原料, 乙酸酐为酰化剂, 一步法选择性地合成氨基二醇类氨基乙酰化产物N-1,3-二羟基丙烷-2-基烷基乙酰胺. 该方法操作简便, 收率高. 所合成的4个新化合物的结构均经FTIR, ¹H NMR, ¹³C NMR及HRMS确证. N-3-(1,3-二羟基丙烷-2-基)丙基乙酰胺(1a)作为关键的中间体, 可以用于HIV-1 Tat/ PCAF BRD抑制剂4的合成.     

First reversible protonation of the all-nitrogen 1-aryl pentazole ring

At −40 °C in chlorosulfonic acid 1-aryl pentazoles were protonated at N-3. The N-3 atom showed a ¹⁵N NMR shielding shift of −60 to −62 ppm. The -N₅ ring is the highest member of the azole series.